Pharming Group (PHGUF.PK) Gives Update on Rhucin EU Marketing Authorization Application
1/22/2010 8:49:50 AM
More...
|
Pharming Group (PHGUF.PK) Provides Business Update
1/12/2010 11:55:50 AM
More...
|
Pharming Group (PHGUF.PK) Obtains Euro 7.5 Million Financing
1/5/2010 6:41:47 AM
More...
|
Pharming Group (PHGUF.PK) Confirms Interaction With US FDA for Rhucin
12/9/2009 10:20:25 AM
More...
|
Pharming Group (PHGUF.PK) Recombinant Human C1 Inhibitor: Results In Pre-Clinical Ischaemic Reperfusion Model Confirm Potential For New Indications
10/22/2009 10:51:59 AM
More...
|
Pharming Group (PHGUF.PK) Announces Third Quarter 2009 Results
10/16/2009 8:52:18 AM
More...
|
Pharming Group (PHGUF.PK) Confirms Successful Closing Of Offer On Convertible Bonds
10/13/2009 10:31:19 AM
More...
|
Pharming Group (PHGUF.PK) Finalizes Conversion Of 70% Of Outstanding Bonds
10/8/2009 10:30:55 AM
More...
|
Pharming Group (PHGUF.PK) Secures Additional EUR 10 Million Financing from Yorkville Advisors
10/5/2009 6:42:27 AM
More...
|
Pharming Group (PHGUF.PK) Provides Update On Outstanding Shares
9/30/2009 10:44:20 AM
More...
|
|